The documentation of a 20% prevalence of depression after stroke1 has important therapeutic implications for patients with significant ischaemic heart disease and/or cardiac arrhythmia coexisting, either coincidentally or in an aetiopathogenetic role, with stroke illness. In such patients therapeutic choices now need to be governed by the recognition that, despite comparable therapeutic benefit, …